文献速递心外重症与机械循环支持

左心室辅助装置植入后感染与1年健康相关生活质量的关系

Infections following left ventricular assist device implantation and 1-year health-related quality of life.
PubMed 文献 · J Heart Lung Transplant · 2023-05-13

基于STS Intermacs登记库2012年4月至2016年10月接受初次左心室辅助装置(LVAD)植入的11,618例患者,41.0%在随访期间发生感染。每增加一次感染,主要复合不良结局(EuroQoL视觉模拟量表<65、太虚弱无法完成问卷或1年死亡)的调整比值比为1.22(95%CI 1.19-1.24,p<0.001),且与EQ-5D多个维度更差的表现相关。

要点

  • 11,618例LVAD患者中4,768例(41.0%)发生感染,2,282例(19.6%)发生>1次感染。
  • 每增加一次感染,主要复合不良结局调整OR为1.22(95%CI 1.19-1.24,p<0.001)。
  • 每增加一次感染与主要复合结局概率增加3.49%相关,并与1年存活者EQ-5D多个维度更差相关。

核心结论

  • 对于接受LVAD植入的患者,植入后第一年内每增加一次感染,均与无健康相关生活质量受损的生存方面产生递增的负面影响相关。

研究设计与样本

  • 研究纳入STS Intermacs登记库中2012年4月至2016年10月期间接受初次LVAD植入的患者,共11,618例,来自161个医疗中心。
  • 主要暴露为植入后一年内感染,包括任何感染、感染总次数和感染类型(LVAD特异性、LVAD相关、非LVAD)。
  • 采用逆概率加权和Cox回归估计感染与主要复合不良结局(定义为EuroQoL视觉模拟量表<65、太虚弱无法完成问卷或1年死亡)之间的关联。

主要发现

  • 研究队列共11,618例患者,来自161个医疗中心,其中4,768例(41.0%)发生感染,2,282例(19.6%)在随访期间发生>1次感染。
  • 每增加一次感染,主要复合不良结局的调整比值比为1.22(95%CI 1.19-1.24,p<0.001)。
  • 每增加一次感染与主要复合结局概率增加3.49%相关。
  • 对于存活至1年的患者,每增加一次感染与EQ-5D评估的多个健康相关生活质量维度更差的表现相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Left ventricular assist device (LVAD) implantation leads to substantial and sustained improvement in health-related quality of life (HRQOL) among patients. Infection following device implantation remains an important and frequent complication and adversely affects patient-reported HRQOL. METHODS: Patients in The Society of Thoracic Surgeons' Interagency Registry for Mechanically Assisted Circulatory Support receiving a primary LVAD between April 2012 to October 2016 were included. The primary exposure was one-year post-implant infection, characterized by: (1) any infection; (2) total number of infections and (3) type (LVAD-specific, LVAD-related, non-LVAD). The association between infection and the primary composite adverse outcome (defined as EuroQoL Visual Analog Scale< 65, too sick to complete the survey, or death at 1-year) was estimated using inverse probability weighting and Cox regression. RESULTS: The study cohort included 11,618 patients from 161 medical centers with 4,768 (41.0%) patients developing an infection, and 2,282 (19.6%) patients having> 1 infection during the follow up period. The adjusted odds ratio for the primary composite adverse outcome was 1.22 (95% CI, 1.19-1.24, p < 0.001) for each additional infection. Each additional infection was associated with a 3.49% greater probability of the primary composite outcome and was associated with worse performance across multiple dimensions of HRQOL as assessed by the EQ-5D for patients who survived to 1 year. CONCLUSIONS: For patients undergoing LVAD implantation, each additional infection within the first post-implantation year was associated with an incremental negative effect on survival free of impaired HRQOL.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Zhou S, Yang G, Hou H, et al. Infections following left ventricular assist device implantation and 1-year health-related quality of life. J Heart Lung Transplant. 2023. PMID: 37187319. doi:10.1016/j.healun.2023.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。